4.7 Article

Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Fascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?

Hongliang Liu et al.

Summary: Fascin actin-bundling protein 1 (FSCN1) is a highly conserved protein that has been found to be overexpressed in various human cancers, where it is associated with aggressive clinical progression, poor prognosis, and survival outcomes. The upregulation of FSCN1 in cancer cells is linked to tumor growth, migration, invasion, and metastasis, making it a potential therapeutic target and biomarker for multiple cancer types.

MOLECULAR THERAPY-ONCOLYTICS (2021)

Article Cell Biology

Fascin inhibitor increases intratumoral dendritic cell activation and anti-cancer immunity

Yufeng Wang et al.

Summary: The discovery of fascin inhibitor NP-G2-044 not only limits tumor metastasis but also reinvigorates anti-tumor immune responses in the tumor microenvironment, potentially increasing overall survival for late-stage cancer patients.

CELL REPORTS (2021)

Review Oncology

Adrenocortical carcinoma: current treatment options

Giuseppina De Filpo et al.

Summary: This article focuses on current and future treatment options for adrenocortical carcinoma (ACC), emphasizing the importance of radical surgery and adjuvant mitotane for patients at high risk of recurrence. Chemotherapy options such as EDP-M, gemcitabine, and temozolomide are discussed. Limited data are available on second-line and third-line chemotherapy for patients with disease progression after EDP-M, with the efficacy of targeted therapies still under evaluation through clinical trials.

CURRENT OPINION IN ONCOLOGY (2021)

Review Endocrinology & Metabolism

Adrenocortical carcinoma - towards genomics guided clinical care

Joakim Crona et al.

NATURE REVIEWS ENDOCRINOLOGY (2019)

Article Medicine, General & Internal

Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment

Soraya Puglisi et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Endocrinology & Metabolism

Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma

Giada Poli et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Review Oncology

The next step: mechanisms driving adrenocortical carcinoma metastasis

Enzo Lalli et al.

ENDOCRINE-RELATED CANCER (2018)

Review Endocrinology & Metabolism

Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis

R. Armignacco et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2018)

Article Medicine, Research & Experimental

Fascin is secreted in male's serum: results of a pilot study

Daniel Porav-Hodade et al.

FUTURE SCIENCE OA (2018)

Article Biochemistry & Molecular Biology

Clinical significance of fascin-1 and laminin-5 in non-small cell lung cancer

L. Yang et al.

GENETICS AND MOLECULAR RESEARCH (2017)

Article Gastroenterology & Hepatology

Tumor-associated autoantibodies against Fascin as a novel diagnostic biomarker for esophageal squamous cell carcinoma

Wen-Xia Chen et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)

Article Oncology

Improving fascin inhibitors to block tumor cell migration and metastasis

Shaoqin Han et al.

MOLECULAR ONCOLOGY (2016)

Review Oncology

The roles of fascins in health and disease

Yosuke Hashimoto et al.

JOURNAL OF PATHOLOGY (2011)